Christopher Compton, MD
Ophthalmology · Louisville, KYNPI 1033345657
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,000 of the $12,938 with a category attached, or 61.8%. Amgen accounts for 84.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $5,484 and has fallen 89.7% since, to $566 in 2025. Among ophthalmology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $95.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$11K
- Alcon$333
- Regeneron Healthcare Solutions, Inc.$244
- Mallinckrodt Enterprises LLC$237
- Novartis$146
- Glaukos Corporation$142
- plus $892 from 15 others
What the payments were for
- Speaking & faculty fees$8,00062%
- Food & beverage$4,93838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 103 | $10,945 |
| Alcon | 3 | $333 |
| Regeneron Healthcare Solutions, Inc. | 2 | $244 |
| Mallinckrodt Enterprises LLC | 2 | $237 |
| Novartis | 4 | $146 |
| Glaukos Corporation | 1 | $142 |
| Genentech, Inc. | 1 | $122 |
| Kala Pharmaceuticals, Inc. | 1 | $120 |
| Ocular Therapeutix, Inc. | 1 | $111 |
| Optovue, Inc. | 1 | $98 |
| Johnson & Johnson | 1 | $97 |
| ANI Pharmaceuticals, Inc. | 1 | $75 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Biotissue Holdings Inc. | 4 | $49 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $45 |
| Stryker | 1 | $36 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Merz North America, Inc. | 1 | $16 |
| Axogen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,938 in reported general payments places this provider in the 95th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 126 | $1,119 |
| Doxycycline Monohydrate | 14 | $252 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $163 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $128 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Louisville
- Jeremy ClarkLouisville$131K
- Guruprasad PattarLouisville$36K
- Gary FoulksLouisville$16K
- Inder SingalLouisville$9K
- Rishi KumarLouisville$8K
- Frank BurnsLouisville$8K
- Steven BloomLouisville$6K
- Sharmini BalakrishnanLouisville$6K
- Sergei DmitrukLouisville$5K
- Lawrence TenkmanLouisville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.